CIR To Consider Reopening Phthalates Safety Assessment
This article was originally published in The Rose Sheet
Executive Summary
With new studies suggesting an association between phthalate levels and diabetes, and a separate study proposing a link between phthalate levels and airway inflammation, the Cosmetic Ingredient Review Expert Panel will decide if the data merit reopening a safety review of phthalates.
You may also be interested in...
CIR: New Research On Controversial Ingredients Should Be Considered
The Cosmetic Ingredient Review Expert Panel will take a look at new research on cosmetic ingredients as needed, even if an ingredient in question is not up for review.
CIR Moves To Reopen Retinol Assessment To Examine New Data
The Cosmetic Ingredient Review Expert Panel will consider new data as it reexamines the safety of retinol and retinyl palmitate in cosmetics. Panel opts not to reopen review of triclosan or parabens.
J&J To Remove Formaldehyde, Other Concerns From Personal-Care Items
In response to consumer demand, J&J will remove controversial ingredients from both baby and adult brands, including Neutrogena, Aveeno, Lubriderm and Clean & Clear.